We investigated mechanism of metformin-induced CSC-inhibitory effect in the field of tumor metabolism, and demonstrated that the CSC-suppressive effect of metformin was associated with AMPK activation/mTOR inhibition and repression of protein prenylation through suppression of mevalonate pathway in colorectal cancer. The gene discussed is MTOR; the disease is neoplasm.